Amphastar Pharmaceuticals, Inc. (AMPH) — Stock Score Summary

Amphastar Pharmaceuticals, Inc. (AMPH) has a MoatMap StockRank of 79/100 based on Quality (61/100), Value (69/100), and Momentum (33/100) factor scores. The current signal is BUY. Amphastar is a specialized biopharmaceutical firm with advanced manufacturing capabilities for complex injectables. While it has strong technical moats, it operates primarily as a product developer rather than a pure-play CDMO, meaning it only partially captures the broad-based pricing power of the CDMO cycle.

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops, manufactures, and markets injectable, intranasal, and inhalation products, focusing on complex generics and proprietary drugs. The company's competitive advantage lies in its expertise with difficult-to-manufacture sterile products and a robust pipeline of both generic and branded pharmaceuticals. It leverages a vertically integrated structure to control critical raw material supply and manufacturing processes.

Key Financial Metrics

Price$20.16
Market Cap$851M
P/E (TTM)11.27
P/E (Forward)5.95
Price/Book1.08
Return on Equity10.4%
Return on Invested Capital10.1%
Debt/Equity88.75
Gross Margin47.3%
Operating Margin8.0%
Revenue Growth0.4%
Free Cash Flow$103M

Amphastar Pharmaceuticals, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Amphastar Pharmaceuticals, Inc.’s (AMPH) StockRank?
MoatMap’s StockRank for Amphastar Pharmaceuticals, Inc. (AMPH) is 79/100, with a Buy signal. It is a composite of Quality (61), Value (69), and Momentum (33) factor ranks across MoatMap’s 19,000+ stock universe.
Does Amphastar Pharmaceuticals, Inc. have an economic moat?
Amphastar Pharmaceuticals, Inc. (AMPH) has a Quality factor score of 61/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Amphastar Pharmaceuticals, Inc. a buy, hold, or sell?
MoatMap’s current signal for Amphastar Pharmaceuticals, Inc. (AMPH) is Buy, based on a StockRank of 79/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Amphastar Pharmaceuticals, Inc. in?
Amphastar Pharmaceuticals, Inc. (AMPH) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).
Browse all ranked stocksAMPH deep dive reportAI ChampionsHow we score stocksSense-check another stock